TAKITA, Sarra (2026). Optical and Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific Aptasensor. Doctoral, Sheffield Hallam University. [Thesis]
Documents
38101:1432126
PDF
Takita_2026_PhD_OpticalAndElectrochemical.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Takita_2026_PhD_OpticalAndElectrochemical.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (14MB) | Preview
Abstract
Prostate cancer (PCa) is one of the most prevalent malignancies among men worldwide.
Although prostate-specific antigen (PSA) testing has improved early detection of PCa,
its limited specificity leads to false positives and false negatives, resulting in overdiagnosis
and unnecessary biopsies. These limitations highlight the need for more accurate,
specific, and non-invasive biomarkers to improve PCa diagnosis. Prostate Cancer
Antigen 3 (PCA3), a long non-coding RNA markedly overexpressed in malignant
prostate tissue and detectable in urine, offers improved diagnostic specificity. However,
commercial PCA3 tests, such as Progensa®, remain complex, costly, and unsuitable for
broad clinical implementation and accessibility, underscoring the need for simple,
sensitive, and non-invasive diagnostic tools for PCa detection. This thesis presents the
development and optimisation of novel aptamer-based biosensing platforms (aptasensors)
for sensitive and selective detection of PCA3. Using the CG3 RNA aptamer, several
electrochemical and optical detection strategies were investigated, including cyclic
voltammetry (CV), differential pulse voltammetry (DPV), electrochemical impedance
spectroscopy (EIS), and total internal reflection ellipsometry (TIRE). Both redox
labelled (ferrocene and methylene blue) and label-free RNA aptamer formats were
immobilised onto a range of nanostructured gold transducers, including screen-printed
gold
electrodes (SPGE) and gold nanoparticle-modified carbon electrodes
(AuNP/SPCE). The sensing platforms demonstrated progressive improvements in
detection sensitivity, with the most advanced label-free EIS-based aptasensor achieving
detection limits of 1 fM in buffer and 20 fM in artificial urine. These results demonstrate
the potential of combining the high sensitivity of nanostructured transducers with
aptamer specificity to achieve ultrasensitive, selective, and cost-effective PCA3 detection
suitable for point-of-care diagnostics. Optical measurements using TIRE, alongside other
surface-characterisation methods such as AFM and SEM, provided complementary
insights into binding kinetics, surface chemistry and aptamer-target interactions. Overall,
this work establishes a robust foundation for ultrasensitive PCA3 detection, highlighting
that aptamer‑based biosensors can provide simple, cost‑effective, non‑invasive, and
highly specific diagnostic tools suitable for point‑of‑care diagnostics applications.
More Information
Statistics
Downloads
Downloads per month over past year
Metrics
Altmetric Badge
Dimensions Badge
Share
Actions (login required)
![]() |
View Item |


Tools
Tools